Hot Deals:
adtech 29.10 (0.34 %) agarwal bolts 1,200.00 (0.00 %) amol minechem 525.00 (1.94 %) anand i-power 20.00 anglo french drugs 745.00 (-0.67 %) apl metals 40.00 (-4.78 %) arkfin investments 50.00 arohan 125.00 (3.31 %) assam carbon 200.00 (2.56 %) atlas copco 10,000.00 (1.01 %) auckland international 129.00 (-0.77 %) av thomas 16,750.00 (1.18 %) axles 220.00 (-2.22 %) balmer lawrie 199.00 (1.02 %) bharat hotels 200.00 (-2.44 %) bima mandi 700.00 bira 600.00 (1.69 %) boat 900.00 (1.12 %) c & s electric 550.00 (0.92 %) cable corporation 12.10 (0.83 %) capgemini 11,111.00 (1.01 %) care health 171.00 (-0.58 %) carrier aircon 290.00 (-3.33 %) cial 189.00 (1.07 %) csfbl 370.00 (-1.33 %) csk 163.00 (-1.21 %) dalmia refract 145.00 (-2.03 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 425.00 (2.66 %) electronica plastic 4,100.00 (-0.24 %) elgi ultra 400.00 elofic 2,100.00 (2.44 %) esl steel 23.00 (0.44 %) fincare business 45.50 (1.11 %) fincare sfbl 136.00 (-2.86 %) finopaytech 139.00 (-0.71 %) flipkart india 231,001.00 (0.00 %) frick india 7,300.00 (2.82 %) gkn driveline 1,250.00 (4.17 %) go digit general insurance ltd 354.00 (1.14 %) godavari bio 71.00 (1.43 %) hdb financial 650.00 (-0.76 %) hdfc ergo 370.00 (1.70 %) hdfc securities 10,800.00 (-0.92 %) hella india 810.00 (1.25 %) hero fincorp 1,160.00 (0.87 %) hexaware 600.00 (1.69 %) hicks 1,450.00 (2.11 %) hira ferro 150.00 (0.67 %) honeywell electrical 3,600.00 (-0.28 %) ikf finance 221.00 (0.45 %) incred financial 100.00 india carbon 900.00 (-1.10 %) india exposition 135.00 (-0.74 %) indian potash 1,300.00 (-0.38 %) indo alusys 25.75 (-0.96 %) indofil 640.00 (-2.29 %) infinite computer 405.00 (1.25 %) inkel 12.00 (-1.64 %) ixigo 96.00 (5.49 %) jana small finance bank 75.00 kel 510.00 (-1.92 %) kial 97.00 (1.04 %) klm axiva 16.20 (0.62 %) kurlon limited 490.00 (-2.00 %) lava 93.00 (-2.11 %) manipal housing 72.50 (0.69 %) manjushree technopack 1,010.00 (1.00 %) martin & harris 1,125.00 (4.17 %) merino 3,030.00 (-2.26 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 405.00 (-3.57 %) mobikwik 315.00 (-1.56 %) mohan meakin 1,640.00 (0.92 %) mohfl 9.25 (-0.54 %) mrhfl 100.00 msei 0.86 (-2.27 %) msil 41.00 (-8.89 %) nayara energy 250.00 (-1.96 %) nayara energy ncd 255.00 (-1.92 %) ncdex 275.00 ncl buildtek 195.00 (-2.99 %) ncl holdings 60.00 (1.69 %) nsdl 700.00 nse 3,400.00 (1.49 %) orbis financial 117.00 (1.74 %) oswal minerals 60.10 (-1.48 %) otis 4,000.00 (2.56 %) oyo 73.00 (1.39 %) panasonic appliances 202.00 (1.00 %) panasonic avc 29.00 (-0.34 %) paymate india 360.00 (2.86 %) pharmeasy 9.00 (-3.23 %) philips domestic 560.00 (-1.75 %) philips india 875.00 (2.94 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 320.00 (1.59 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 405.00 (1.25 %) resins plastics 415.00 (-1.89 %) ring plus aqua 405.00 (0.25 %) rrl 1,275.00 (2.00 %) sab miller 365.00 (-3.69 %) sbi amc 1,075.00 (1.90 %) sbi general insurance 569.00 scottish assam 446.00 (0.68 %) shriram life 261.00 (0.38 %) sigachi laboratories 39.00 (-2.74 %) signify 1,510.00 (0.67 %) smile microfinance 54.00 (3.85 %) sportskeeda 3,303.00 sterlite power 520.00 (1.96 %) studds 830.00 (-0.60 %) svsml 333.00 (-4.86 %) swiggy 361.00 (0.28 %) t stanes 770.00 (2.67 %) tata capital 450.00 (1.12 %) tata tech 925.00 (-0.54 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,200.00 (1.69 %) utkarsh coreinvest 190.00 (2.70 %) vadilal dairy 10.00 vikram solar 350.00 (2.94 %) waree energies 800.00 (3.90 %) zylog 0.01 (-0.99 %)
×

Wintac Delisted Share Price

Company Name
Wintac Limited
Scrip Name
WINTAC
Last Traded Price
207.00
+ 0.98 %
Sector
Pharma
PAN No.
AAACR8613H
Face Value
10
No. of Outstanding Shares
10,024,242
EPS
14.459
PE ratio
14.316
Market Capitalization
207.50 Crore
Book value
5.257
P/BV
39.3761
ISIN No.
INE812C01016
Available on
nsdlcdsl
ROFR Require
No

Wintac Limited Delisted Share - Company Overview

WINTAC LIMITED was established as an offspring of Bangalore Pharmaceuticals and Research Laboratories Private Limited under the name of RECON LIMITED. In 2001, the name of the company was changed to Wintac Limited. The Company is engaged in the business of manufacturing goods and all its other activities revolve around this business. The company’s range of specialties includes Large and small-volume injectable and Ophthalmic solutions.

The delisting open offer for shares of WINTEC LIMITED was successful as per Regulation 17 of the Delisting Regulations at an exit price of `350 per share under the Reverse Book Building Process. The BSE vide its’ notice no. 20201211-16 dated December 11, 2020, communicated that the trading in the Equity Shares of the Company WINTEC LIMITED   (Scrip Code: 524758) will be discontinued from December 18, 2020, and the scrip will be delisted from Exchange records with effect from December 28, 2020. 

Wintac Limited provides outsourcing for sterile pharmaceutical products and Ophthalmic Solutions. Wintac Limited takes care of its customers from formulation development to commercial manufacturing.

The product range of the company includes a wide range of ophthalmic preparations and Injectables of Large and small volume parenteral.

The equity shares of the company have been delisted from the Bombay Stock Exchange of India on December 28, 2020.

Wintac Limited Incorporation Details

CIN of Wintac Limited

L85110KA1990PLC011166

Registration Date of Wintac Limited

23 August 1990

Category/Sub-category of Wintac Limited

Public Limited

Wintac Limited Registered office address and contact details

54/1, BOODHIHAL, NELAMANGALA,

BENGALURU - 562123.

PH:- 080-67086500

Wintac Limited Registrar and Transfer Agent address and contact details

CANBANK COMPUTER SERVICES LTD.,

NO.218, J.P.ROYALE, II MAIN, SAMPIGE ROAD,

MALLESWARAM, BANGALORE - 560003.

PH: 080-23469661/9662

Wintac Limited Principal Business Activities

Name and Description of main products/services

NIC Code of the product/service

% to the total turnover of the Company

Formulation Sales

99532693

80.65%

Manufacturing Charges

99532693

0.21%

Formulation Development

99839390

19.14%

Wintac Limited Board of Directors

Shri S.T.R. Mady (Chairman)

Shri S. Jayaprakash Mady (Director)

Shri R.A. Thirumoorti (Director)

Dr. K. Paranjothy (Director)

Ms. S. Nanthitha (Additional Director)

Mr. Arshad Kagalwalla (Additional Director)

Shri Sunil B. Gundewar (Manager & C.O.O)

Shri B.P. Thyagaraj V.P. (Finance) & Secretary

Particulars of Subsidiary and Associate Companies

Wintac Limited does not have any subsidiary or associate company.

Shareholding Pattern (As of 31-03-2020)

S. No.

Shareholders’ Name

Number of shares

% of total Shares of the company

1

VEEGO Pharma LLC (Promoter)

92,40,346

92.18%

2

Public Shareholding

7,83,896

7.82%

 

Total

1,00,24,242

100.00%

Industry Outlook

 Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment availability has helped India to manufacture pharma products at a very low cost.

The Indian healthcare market may see a 3 fold jump in terms of value to reach US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.

Export of Pharmaceuticals products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat the covid patients in the initial stage of the covid-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.

After the onset of COVID 19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector. 

 

Annual Report

Wintac Annual Report 2020-21

Download

Wintac Annual Report 2019-20

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha